Myocardial infarction as a first clinical manifestation of hyperthyroidism
More details
Hide details
Provincial Specialist Hospital in Olsztyn, Poland
Department of Medical Sciences, University of Warmia and Mazury in Olsztyn, Poland
Submission date: 2014-04-07
Acceptance date: 2015-03-12
Online publication date: 2015-04-21
Publication date: 2020-03-26
Corresponding author
Sonia J. Konsek   

Żorska 140B, 44-203 Rybnik, Poland. Tel.: +48 606 973 348.
Pol. Ann. Med. 2015;22(2):139–142
Hyperthyroidism is a condition in which there is an increased secretion of thyroid hormones that exceeds the current needs of the body. Increased concentrations of hormones affect proper functioning of many organs and systems, including the cardiovascular system. Untreated hyperthyroidism may result in myocardial infarction (MI), which very rarely is its first clinical manifestation.

The aim of this work is to present the case of a male patient with no previous symptoms, in whom ST segment elevation myocardial infarction (STEMI) occurred as the first clinical manifestation of hyperthyroidism.

Case study:
Presentation and analysis of the case of a 41-year-old male admitted with clinical and electrocardiographic features of anterior wall STEMI in the course of hyperthyroidism.

Results and discussion:
The cause of ischemia and MI in patients with no previous coronary artery disease is not fully known. Probable predisposing factors may include increased serum thyroid hormone concentrations. It enhances the vasoconstrictor effect of catecholamines and hyperkinetic circulation, which may be the potential causes of ischemia. In addition, it predisposes to a hypercoagulable state, which is the cause of coronary thrombosis.

It is not only high cholesterol levels and anemia that are the possible causes of MI. Endocrine disorders, such as hyperthyroidism should always be taken into account.

None declared.
Kuang XH, Zhang SY. Hyperthyroidism-associated coronary spasm: a case of non-ST segment elevation myocardial infarction with thyrotoxicosis. J Geriatr Cardiol. 2011;8(4):258–259.
Fater-Dębska A, Gworys P, Brzeziński J, Gawor Z. Thyrometabolic disorders and heart failure. Endokrynol Pol. 2007;58(3):228–233 [in Polish].
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–509.
Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87(5):1435–1441.
Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011;124:1774–1782.
Moliterno D, DeBold CR, Robertson RM. Case report: coronary vasospasm – relation to the hyperthyroid state. Am J Med Sci. 1992;304(1):38–42.
Khono A, Hara Y. Severe myocardial ischemia following hormone replacement in two cases of hypothyroidism with normal coronary arteriogram. Endocr J. 2001;48(5):565–572.
Resnekov L, Falicov RE. Thyrotoxicosis and lactateproducing angina pectoris with normal coronary arteries. Br Heart J. 1977;39(10):1051–1057.
Gordon JAL, Lenkei SCM. Thyrotoxicosis associated with myocardial infarction. Can Med Assoc J. 1964;90(19):1128–1129.
Iwańczuk W. Myocardial infarction and shock associated with thyrotoxicosis. Anestezjol Intens Ter. 2010;42(3):126–130 [in Polish].
Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87(1):76–79.
Ashikaga T, Nishizaki M, Fujii H, et al. Examination of the microcirculation damage in smokers versus nonsmokers with vasospastic angina pectoris. Am J Cardiol. 2007;100(6):962–964.
Sakaki T, Fujioka F, Akagami T, et al. Cardiac wall motion abnormalities observed in a patient with transient hyperthyroidism. Jpn Heart J. 2004;45(6):1071–1077.
Symmes JC, Lenkei SC, Berman ND. Myocardial infarction, hyperthyroidism and normal coronary arteries: report of two cases. Can Med Assoc J. 1977;117(5):489–491.
Masani ND, Northridge DB, Hall RJ. Severe coronary vasospasm associated with hyperthyroidism causing myocardial infarction. Br Heart J. 1995;74(6):700–701.